(Date:9/4/2008)... may be shortchanging their golden years by tappin...iversity of Illinois expert who has studied the fe..., More than three of every four Americans trim th...iming benefits early, a choice many might forego i... consequences, law professor Richard L. Kaplan say...
(Date:9/4/2008)...ncology contract research organization, has publis...uanced Approach to Get Into the Clinic Faster.&quo...al research scientist with 35 years of experience,...mmonly viewed as straightforward investigations ru...rue integration with preclinical, regulatory and c...
(Date:9/4/2008)...NORWICH, England and ONGAR, Ireland,Sept. 4 /PRNe...ofield Media,Europe Ltd, announced on the 29th Aug... publication from Silverdog Publishing., Health a... the iconic,Health and Safety at Work Act 1974 and.... It has been relied upon by blue-chip corporates,...
(Date:9/4/2008)...-FirstCall/ -- ULURU Inc. (Amex:,ULU) today announ...Weisel,Partners Healthcare Conference at 3:15 p.m....out ULURU Inc.:, ULURU Inc. is an emerging specia...ent of a portfolio of wound management, plastic su...nd consumers improved clinical,outcomes through co...
Breaking Medicine News(10 mins):Health News:New guide explores making the most of Social Security 2Health News:New guide explores making the most of Social Security 3Health News:Oncology Clinical Research Scientist Recommends a Nuanced Preclinical Study Process to Speed Drug Development 2Health News:Oncology Clinical Research Scientist Recommends a Nuanced Preclinical Study Process to Speed Drug Development 3Health News:Schofield Publishing Enters the Newsletter Market 2(Date:9/4/2008)...) real-time PCR testing for the diagnostic ..., Sept. 4 /- The U.S. Food & Drug,Adm...TaqMan(R) HBV Test,the first assay for quantitati...test uses Roche,s real-time PCR technology to quan...ent,s blood. Doctors may use viral load,testing re...
(Date:9/4/2008)...er 4 /- Axentis Pharma AG has,initiat... and tolerability,of a new therapeutic formulation...n cystic fibrosis patients. The new formulation al...red directly to the site of,infection. The forthco...fferent doses of the new drug. Initial results are...
(Date:9/3/2008)...Xinhua--,Pharmaceutical com...unced,that it has enrolled the first subject into ...ng Bronchitol in cystic fibrosis sufferers., The ...cross North,America, Argentina and Germany, and is...proval to market Bronchitol for cystic fibrosis in...
(Date:9/3/2008)... Vascular Disease Awareness Month, CHARLOTTESVILL...uticals,LLC, a clinical-stage drug-development com...f unmet medical needs, announced today that it has... trial of its lead drug,candidate trans sodium cro...on the clinicaltrials.gov Website, is investigatin...
Breaking Medicine Technology:FDA Approves First Hepatitis B Viral Load Test 2FDA Approves First Hepatitis B Viral Load Test 3Cystic Fibrosis Axentis Pharma Initiates Clinical Trial for Lung Infections 2Cystic Fibrosis Axentis Pharma Initiates Clinical Trial for Lung Infections 3Cystic Fibrosis Axentis Pharma Initiates Clinical Trial for Lung Infections 4Second Pivotal Phase 3 Trial In Cystic Fibrosis Begins 2Second Pivotal Phase 3 Trial In Cystic Fibrosis Begins 3Diffusion Pharmaceuticals Announces Initiation of a Phase I/II Clinical Trial in Patients with Peripheral Arterial Disease (PAD) 2Diffusion Pharmaceuticals Announces Initiation of a Phase I/II Clinical Trial in Patients with Peripheral Arterial Disease (PAD) 3Diffusion Pharmaceuticals Announces Initiation of a Phase I/II Clinical Trial in Patients with Peripheral Arterial Disease (PAD) 4New Book Links Motorcycle Radiation to Cancer Risk 6696 1New Book Links Motorcycle Radiation to Cancer Risk 6696 2Rogue bacteria involved in both heart disease and infertility 6693 1Rogue bacteria involved in both heart disease and infertility 6693 2Rogue bacteria involved in both heart disease and infertility 6693 3Orchid Cellmark Appoints William J Thomas Vice President and General Counsel 6690 1Orchid Cellmark Appoints William J Thomas Vice President and General Counsel 6690 2Orchid Cellmark Appoints William J Thomas Vice President and General Counsel 6690 3Through Wave Ultrasound 3A Effective Economical and Ideal for Breast Imaging Biopsy 6687 1Through Wave Ultrasound 3A Effective Economical and Ideal for Breast Imaging Biopsy 6687 2...S WIRE)--May 25, 2007 - GTx, Inc., (NASDAQ:,GTXI) ... proof of,concept clinical trial of Ostarine(TM) a...ating ACAPODENE(R) (toremifene citrate) 80,mg for ...,deprivation therapy (ADT) will be presented at th...iety of Clinical Oncology being,held June 1 - 5 at...
...)--May 29, 2007 - Pfizer said today that,results s...such as,melanoma, thyroid, liver, non-small cell l...noma (RCC) - a type of advanced kidney,cancer - wi...of,Clinical Oncology (ASCO) annual meeting in Chic...y to treatment, so,it,s critical that physicians h...
Other Medicine Technology:GTx Announces Presentation of Ostarine and Acapodene Data at 2007,ASCO Annual Meeting 2GTx Announces Presentation of Ostarine and Acapodene Data at 2007,ASCO Annual Meeting 3New Pfizer Oncology Data Across Numerous Cancer Types to be,Presented at ASCO 2New Pfizer Oncology Data Across Numerous Cancer Types to be,Presented at ASCO 3New Pfizer Oncology Data Across Numerous Cancer Types to be,Presented at ASCO 4New Pfizer Oncology Data Across Numerous Cancer Types to be,Presented at ASCO 5Foraminotomy Kerrison Rongeurs
Synovectomy Rongeur
Fried Rongeurs
Tiemann Double Action 6" Bone Rongeur
Medicine Products: